טוען...
Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
PURPOSE: Epidermal growth factor receptor (EGFR) is considered a potential therapeutic target for anti-EGFR therapy in triple-negative breast cancer (TNBC). However, the frequency of EGFR gene mutation in TNBC is low and varies with ethnicity. This study aimed to investigate the incidence of EGFR ge...
שמור ב:
| הוצא לאור ב: | J Breast Cancer |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Breast Cancer Society
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5500398/ https://ncbi.nlm.nih.gov/pubmed/28690651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2017.20.2.150 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|